The National Institutes of Health (NIH) intends to award a non-competitive contract to Sartorius Corporation for preventive maintenance services on two government-owned Sartorius Incucyte S3 instruments. The services will be performed on-site at the NIH facility in Bethesda, Maryland, from July 1, 2026, to March 31, 2027. The total contract value is not expected to exceed the simplified acquisition threshold of $350,000. This is a notice of intent, not a request for competitive proposals, but interested parties may submit capability statements by the specified response time.